Robyn Loureiro

560 total citations
14 papers, 451 citations indexed

About

Robyn Loureiro is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Robyn Loureiro has authored 14 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Robyn Loureiro's work include Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Robyn Loureiro is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Robyn Loureiro collaborates with scholars based in United States, China and Canada. Robyn Loureiro's co-authors include Patrìcia A. D'Amore, Tony E. Walshe, Emily A. Dennstedt, Brad A. Bryan, James K. Liao, Kensuke Noma, Magali Saint‐Geniez, Dianne Mitchell, Timothy D. McKee and Barbara Tate and has published in prestigious journals such as Cancer Research, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Robyn Loureiro

14 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robyn Loureiro United States	9	282	95	76	63	63	14	451
Bhramdeo Bassit United States	7	360 1.3×	200 2.1×	40 0.5×	71 1.1×	82 1.3×	7	532
Andreas Anders United Kingdom	8	257 0.9×	110 1.2×	51 0.7×	103 1.6×	127 2.0×	8	458
Olivier Defert Belgium	8	352 1.2×	66 0.7×	22 0.3×	87 1.4×	76 1.2×	14	677
Fredrik Jerhammar Sweden	10	198 0.7×	96 1.0×	94 1.2×	123 2.0×	71 1.1×	11	395
Bin Yuan China	11	167 0.6×	97 1.0×	43 0.6×	137 2.2×	31 0.5×	19	410
Christine R. Hoffman United States	10	344 1.2×	35 0.4×	68 0.9×	155 2.5×	70 1.1×	12	554
Zhongping Liao United States	8	221 0.8×	151 1.6×	48 0.6×	30 0.5×	38 0.6×	12	356
Nicolas Currier United States	9	381 1.4×	44 0.5×	69 0.9×	147 2.3×	29 0.5×	11	649
C. Geeth Gunawardana Canada	9	284 1.0×	80 0.8×	53 0.7×	64 1.0×	33 0.5×	10	474
Wen‐Liang Kuo United States	11	344 1.2×	98 1.0×	72 0.9×	95 1.5×	75 1.2×	17	493

Countries citing papers authored by Robyn Loureiro

Since Specialization

Citations

This map shows the geographic impact of Robyn Loureiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn Loureiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn Loureiro more than expected).

Fields of papers citing papers by Robyn Loureiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn Loureiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn Loureiro. The network helps show where Robyn Loureiro may publish in the future.

Co-authorship network of co-authors of Robyn Loureiro

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn Loureiro. A scholar is included among the top collaborators of Robyn Loureiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn Loureiro. Robyn Loureiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hubbs, Jed L., Nathan O. Fuller, Ruichao Shen, et al.. (2015). Minimization of drug–drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 25(7). 1621–1626. 6 indexed citations

Loureiro, Robyn, Jo Ann Dumin, Timothy D. McKee, et al.. (2013). Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models. Alzheimer s Research & Therapy. 5(2). 19–19. 20 indexed citations

Hubbs, Jed L., Nathan O. Fuller, Steffen P. Creaser, et al.. (2013). SAR investigations on a novel class of gamma-secretase modulators based on a unique scaffold. MedChemComm. 4(3). 569–569. 8 indexed citations

McKee, Timothy D., Robyn Loureiro, Jo Ann Dumin, Vladislav Zarayskiy, & Barbara Tate. (2012). P2‐095: An improved cell‐based method for determining the gamma‐secretase enzyme activity against both Notch and APP substrates. Alzheimer s & Dementia. 8(4S_Part_8). 2 indexed citations

Tate, Barbara, Timothy D. McKee, Robyn Loureiro, et al.. (2012). Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease. International Journal of Alzheimer s Disease. 2012. 1–10. 20 indexed citations

Hubbs, Jed L., Nathan O. Fuller, Ruichao Shen, et al.. (2012). Optimization of a Natural Product-Based Class of γ-Secretase Modulators. Journal of Medicinal Chemistry. 55(21). 9270–9282. 38 indexed citations

McKee, Timothy D., Robyn Loureiro, Jo Ann Dumin, Vladislav Zarayskiy, & Barbara Tate. (2012). An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates. Journal of Neuroscience Methods. 213(1). 14–21. 12 indexed citations

Loureiro, Robyn, Timothy D. McKee, Jo Ann Dumin, et al.. (2012). O1‐11‐01: Satori gamma‐secretase modulators are efficacious in wild‐type rodents following either acute or steady‐state dosing. Alzheimer s & Dementia. 8(4S_Part_3). 1 indexed citations

Fuller, Nathan O., Jed L. Hubbs, Steffen P. Creaser, et al.. (2012). Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside. ACS Medicinal Chemistry Letters. 3(11). 908–913. 18 indexed citations

10.

Xia, Weiming, Timothy D. McKee, Robyn Loureiro, et al.. (2011). P2‐513: Classification of γ‐secretase modulators and their effect on pharmacological profiles of amyloid β peptides. Alzheimer s & Dementia. 7(4S_Part_14). 1 indexed citations

11.

Bryan, Brad A., Emily A. Dennstedt, Dianne Mitchell, et al.. (2010). RhoA/ROCK signaling is essential for multiple aspects of VEGF‐mediated angiogenesis. The FASEB Journal. 24(9). 3186–3195. 221 indexed citations

12.

Harper, Jay, Yan Li, Robyn Loureiro, et al.. (2007). Repression of Vascular Endothelial Growth Factor Expression by the Zinc Finger Transcription Factor ZNF24. Cancer Research. 67(18). 8736–8741. 44 indexed citations

13.

Loureiro, Robyn, Arindel S.R. Maharaj, David Dankort, William J. Muller, & Patrìcia A. D'Amore. (2004). ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter. Biochemical and Biophysical Research Communications. 326(2). 455–465. 23 indexed citations

14.

Ng, Yin‐Shan, Markus Ramsauer, Robyn Loureiro, & Patrìcia A. D'Amore. (2004). Identification of genes involved in VEGF-mediated vascular morphogenesis using embryonic stem cell-derived cystic embryoid bodies. Laboratory Investigation. 84(9). 1209–1218. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact